<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019148</url>
  </required_header>
  <id_info>
    <org_study_id>SU-11182009-4402</org_study_id>
    <nct_id>NCT01019148</nct_id>
  </id_info>
  <brief_title>Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa</brief_title>
  <official_title>Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in&#xD;
      the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters&#xD;
      and open wounds from minor trauma to their skin. We are screening subjects with RDEB to&#xD;
      evaluate characteristics of the subjects and their cells in order to develop new strategies&#xD;
      of therapy and determine whether subjects could be candidates for treatment studies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will obtain a detailed medical history and will perform a skin examination and brief&#xD;
      physical exam. Photographs may be taken. We will ask questions about the size and duration&#xD;
      wounds.&#xD;
&#xD;
      LAB TESTS We will draw blood to determine overall health status to include Hepatitis B,&#xD;
      Hepatitis C, and Human Immunodeficiency Virus (HIV) testing. Genetic testing may also be&#xD;
      performed.&#xD;
&#xD;
      BIOPSIES Biopsies may be collected to check for Collagen 7 and for antibodies to Collagen 7.&#xD;
&#xD;
      Based on the results obtained, it may be possible to identify patients who would qualify to&#xD;
      participate in current or future clinical trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 10, 2009</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of subjects with Recessive Dystrophic Epidermolysis Bullosa</measure>
    <time_frame>4 years</time_frame>
    <description>Identification of subjects with Recessive Dystrophic Epidermolysis Bullosa for future studies</description>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Epidermolysis Bullosa Dystrophica</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Skin biopsies, serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with RDEB by a local dermatologist who are medically stable enough to&#xD;
        travel to Stanford University Medical Center. Patients should also be at least 7 years of&#xD;
        age.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of RDEB by local dermatologist&#xD;
&#xD;
          -  7 years of age or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Medical instability limiting ability to travel to Stanford University Medical Center&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Tang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irene Bailey-Healy</last_name>
    <phone>(650) 721-7149</phone>
    <email>baileyhi@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicki Harris</last_name>
    <email>nharris6@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Bailey-Healy</last_name>
      <phone>650-721-7149</phone>
      <email>baileyhi@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Jean Tang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>M. Peter Marinkovich, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Oro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 20, 2009</study_first_submitted>
  <study_first_submitted_qc>November 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Jean Yuh Tang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epidermolysis Bullosa</mesh_term>
    <mesh_term>Epidermolysis Bullosa Dystrophica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

